SLNO Soleno Therapeutics Inc.

Fundamentals / CIK 0001484565 / USD

Soleno Therapeutics Inc. reported $190.4M in revenue and net income of $96.04M for the fiscal year ended December 31, 2025, with a 98.6% gross margin and a 45.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SLNO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$206.2M$103.1M$0-$180.6MFY 2016 Revenue: $1.45MFY 2016 Net Income: -$12.07M2016FY 2017 Net Income: -$15.38M2017FY 2018 Net Income: -$13.34M2018FY 2019 Net Income: -$30.77M2019FY 2020 Net Income: -$24.64M2020FY 2021 Net Income: -$30.91M2021FY 2022 Net Income: -$24.07M2022FY 2023 Net Income: -$38.99M2023FY 2024 Net Income: -$175.8M2024FY 2025 Revenue: $190.4MFY 2025 Net Income: $20.89M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $190.4M -- -- -- -- -- -- -- -- $1.45M
Cost of Revenue $2.70M -- -- -- -- -- -- -- -- $1.51M
Gross Profit $187.7M -- -- -- -- -- -- -- -- -$59K
Research & Development $40.63M $78.57M $25.19M $15.27M $21.45M $23.19M $16.27M $7.18M $3.07M $2.25M
Selling, General & Admin $132.1M $105.9M $13.48M -- -- -- -- -- $6.61M $6.08M
Total Operating Expenses $181.0M $187.7M $41.38M $24.40M $31.53M $36.29M $23.49M $14.30M $12.17M $8.32M
Operating Income $9.41M -$187.7M -$41.38M -$24.40M -$31.53M -$36.29M -$23.49M -$14.30M -$12.17M -$8.32M
EBITDA $11.43M -$185.7M -$39.43M -$22.43M -$29.57M -$34.34M -$21.53M -$12.34M -$10.56M -$8.31M
Interest Income $16.95M $12.05M $2.58M $300K -- -- -- -- -- --
Interest Expense $5.48M $231K $0 $0 -- -- -- -- -- --
Income Before Tax $20.89M -$175.8M -$38.99M -$24.07M -$30.91M -$24.64M -$30.77M -$11.84M -$13.44M -$6.74M
Income Tax Expense $0 $0 $0 -- -- -- -- $0 -$1.65M $0
Net Income $20.89M -$175.8M -$38.99M -$24.07M -$30.91M -$24.64M -$30.77M -$13.34M -$15.38M -$12.07M
Basic EPS $0.40 -$4.38 -$2.36 -$2.87 -$1,017.42 -$1,024.43 -$2,364.06 -$1,681.11 -$4,491.71 -$13,317.53
Diluted EPS $0.39 -$4.38 -$2.36 -$2.87 -$1,017.42 -$1,024.43 -$2,364.06 -$1,681.11 -$4,491.71 -$13,317.53
Basic Shares Outstanding 50.8M 40.2M 16.5M 8.4M 30.4K 23.8K 13.0K 8.0K 3.4K 1.2K
Diluted Shares Outstanding 52.4M 40.2M 16.5M 8.4M 30.4K 23.8K 13.0K 8.0K 3.4K 1.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue $94.60M -- $66.02M $32.66M -- -- -- --
Cost of Revenue $1.20M -- $1.14M $696K -- -- -- --
Gross Profit $93.41M -- $64.88M $31.96M -- -- -- --
Research & Development $11.27M $9.56M $8.40M $9.15M $13.52M $21.49M $30.14M $12.34M
Selling, General & Admin $50.37M $40.88M $33.75M $28.24M $29.26M $37.30M $49.20M $10.89M
Total Operating Expenses $63.33M $52.15M $43.91M $39.18M $45.74M $59.12M $80.21M $24.87M
Operating Income $31.28M $39.58M $22.11M -$6.53M -$45.74M -$59.12M -$80.21M -$24.87M
EBITDA $31.79M $40.09M $22.61M -$6.02M -$45.24M -$58.61M -$79.71M -$24.37M
Interest Income $4.93M $5.13M $5.30M $3.19M $3.33M $3.37M $3.60M $3.01M
Interest Expense $1.29M $1.35M $1.39M $1.38M $1.36M -- -- --
Income Before Tax $34.91M -- -- -- -$43.77M -- -- --
Income Tax Expense $3.54M -- -- -- $0 -- -- --
Net Income $31.38M $43.36M $26.01M -$4.71M -$43.77M -$55.98M -$76.62M -$21.85M
Basic EPS $0.60 -- $0.49 -$0.09 -$0.95 -- -$1.83 -$0.57
Diluted EPS $0.59 -- $0.47 -$0.09 -$0.95 -- -$1.83 -$0.57
Basic Shares Outstanding 52.1M -- 53.3M 50.5M 46.2M -- 41.9M 38.6M
Diluted Shares Outstanding 53.1M -- 54.9M 50.5M 46.2M -- 41.9M 38.6M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $70.11M $87.93M $169.7M $14.60M $21.30M $49.22M $20.73M $23.10M $17.10M $2.73M
Short-Term Investments $235.4M $203.5M -- -- -- -- -- -- -- --
Cash & Short-Term Investments $305.5M $291.4M $169.7M $14.60M $21.30M $49.22M $20.73M $23.10M $17.10M $2.73M
Accounts Receivable, Net $28.21M -- -- -- -- -- -- $0 -- $3.0K
Inventory $15.02M -- -- -- -- -- -- $0 -- $0
Total Current Assets $355.8M $293.9M $171.4M $15.65M $22.42M $50.24M $21.14M $24.67M $17.99M $3.80M
Property, Plant & Equipment, Net $185K $186K $12K $26K $33K $19K $22K $12K $23K $42K
Goodwill -- -- -- -- -- -- -- -- -- $718K
Intangible Assets $4.86M $6.80M $8.75M $10.69M $12.64M $14.58M $16.52M $18.47M $20.41M $817K
Long-Term Investments $200.6M $27.21M -- -- -- -- -- -- -- --
Other Non-Current Assets $163K $83K $165K -- $40K $15K $59K -- $126K $126K
Total Non-Current Assets $208.0M $37.08M $9.33M $10.85M $13.13M $14.74M $17.03M $18.48M $21.03M $1.76M
Total Assets $563.8M $331.0M $180.7M $26.50M $35.55M $64.98M $38.17M $43.15M $39.02M $5.56M
Accounts Payable $12.44M $8.88M $3.15M $1.78M $3.25M $3.49M $2.00M $934K $633K $411K
Other Current Liabilities $18.20M $4.56M $1.55M $484K $323K $196K $382K $349K -- --
Total Current Liabilities $61.36M $18.75M $11.51M $7.31M $8.01M $8.62M $4.96M $1.88M $1.73M $1.71M
Long-Term Debt $49.86M $49.83M -- -- -- -- -- -- -- --
Other Non-Current Liabilities $525K $21K -- -- -- -- $147K -- $13K $62K
Total Non-Current Liabilities $52.35M $67.11M $11.68M $8.84M $9.75M $10.82M $18.26M $10.86M $10.47M $422K
Total Liabilities $113.7M $85.86M $23.18M $16.15M $17.76M $19.43M $23.23M $12.74M $12.21M $2.13M
Total Debt (incl. Leases) $52.55M $52.83M $403K $155K $457K $147K $470K -- -- --
Common Stock $52K $46K $32K $8.0K $80K $80K $45K $32K $19K $3.4K
Retained Earnings -$431.4M -$452.3M -$276.4M -$237.4M -$213.4M -$182.4M -$157.8M -$127.0M -$113.7M -$98.31M
Accumulated Other Comp. Income $415K $361K -- -- -- -- -- -- -- --
Total Stockholders' Equity $450.1M $245.1M $157.5M $10.35M $17.79M $45.55M $14.95M $30.41M $26.82M $3.44M
Total Equity $450.1M $245.1M $157.5M $10.35M $17.79M $45.55M $14.95M $30.41M $26.82M $3.44M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Cash & Cash Equivalents $133.0M $70.11M $246.7M $76.50M $81.33M $87.93M $48.41M $57.02M
Short-Term Investments $122.6M $235.4M $252.3M $210.3M $208.6M $203.5M $208.4M $209.1M
Cash & Short-Term Investments $255.6M $305.5M $498.9M $286.8M $289.9M $291.4M $256.8M $266.1M
Accounts Receivable, Net $47.14M $28.21M $25.51M $24.62M -- -- -- --
Inventory $17.31M $15.02M $6.67M $2.35M -- -- -- --
Total Current Assets $326.4M $355.8M $534.9M $316.8M $308.9M $293.9M $258.2M $267.5M
Property, Plant & Equipment, Net $202K $185K $150K $166K $173K $186K $196K $19K
Intangible Assets $4.37M $4.86M $5.35M $5.83M $6.32M $6.80M $7.29M $7.78M
Long-Term Investments $273.4M $200.6M $57.15M $7.00M $0 $27.21M $27.95M $28.48M
Other Non-Current Assets $163K $163K $83K $83K $83K $83K $83K $83K
Total Non-Current Assets $282.0M $208.0M $65.04M $15.52M $9.18M $37.08M $38.51M $36.63M
Total Assets $608.4M $563.8M $599.9M $332.3M $318.1M $331.0M $296.7M $304.1M
Accounts Payable $12.39M $12.44M $8.14M $6.22M $5.48M $8.88M $6.24M $3.72M
Other Current Liabilities $24.93M $18.20M $17.16M $5.51M $3.13M $4.56M $3.10M $1.13M
Total Current Liabilities $58.05M $61.36M $33.25M $20.94M $15.73M $18.75M $14.96M $9.15M
Long-Term Debt $49.87M $49.86M $49.85M $49.84M $49.84M $49.83M -- --
Other Non-Current Liabilities $1.43M $525K $398K $271K $145K $21K -- --
Total Non-Current Liabilities $54.54M $52.35M $71.84M $71.22M $70.10M $67.11M $17.05M $14.22M
Total Liabilities $112.6M $113.7M $105.1M $92.17M $85.83M $85.86M $32.01M $23.37M
Total Debt (incl. Leases) $54.28M $52.55M $52.66M $52.77M $52.79M $52.83M $3.03M $296K
Common Stock $52K $52K $54K $50K $49K $46K $41K $38K
Retained Earnings -$400.0M -$431.4M -$474.7M -$500.7M -$496.0M -$452.3M -$396.3M -$319.7M
Accumulated Other Comp. Income -$1.84M $415K $360K $85K $226K $361K $895K -$153K
Total Stockholders' Equity $495.8M $450.1M $494.8M $240.1M $232.3M $245.1M $264.7M $280.8M
Total Equity $495.8M $450.1M $494.8M $240.1M $232.3M $245.1M $264.7M $280.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $20.89M -$175.8M -$38.99M -$24.07M -$30.91M -$24.64M -$30.77M -$13.34M -$15.38M -$12.07M
Depreciation & Amortization $2.02M $1.99M $1.96M $1.96M $1.96M $1.95M $1.96M $1.96M $1.61M $19K
Stock-Based Compensation $45.85M $99.96M $5.95M $2.53M $3.28M $1.50M $825K $1.26M $880K $739K
Change in Receivables -$28.21M $0 $0 -- -- -- -- -- -- $23K
Change in Inventory -$14.03M $0 $0 -- -- -- -- -- -- -$109K
Change in Payables $3.61M $5.67M $1.37M -$1.48M -$235K $1.49M $1.06M $249K $191K -$77K
Operating Cash Flow $46.80M -$69.10M -$24.94M -$20.78M -$27.77M -$25.22M -$17.38M -$11.68M -$9.95M -$13.50M
Capital Expenditure -$73K -$218K $0 -$13K -$22K -$7.0K -$21K -$8.0K -$2.0K -$15K
Free Cash Flow $46.73M -$69.31M -$24.94M -$20.79M -$27.79M -$25.23M -$17.40M -$11.69M -$9.95M -$13.51M
Acquisitions, Net -- -- -- -- -- -- -- -- -$573K $0
Purchases of Investments -$455.8M -$356.5M $0 $0 -- -- -- -- -- --
Investing Cash Flow -$201.8M -$225.7M $0 -$13K -$22K -$7.0K $528K -$180K $154K -$39K
Common Stock Issued $215.7M $149.0M $0 $0 -- -- -- -- $10.00M $0
Share Repurchases -$100.1M $0 $0 -- -- -- -- -- -- --
Financing Cash Flow $137.2M $213.0M $180.0M $14.09M -$128K $53.72M $14.48M $17.83M $24.17M $10.77M
Net Change in Cash -$17.82M -$81.75M $155.1M -$6.70M -$27.92M $28.49M -$2.37M $5.96M $14.37M -$2.77M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Net Income $31.38M $43.36M $26.01M -$4.71M -$43.77M -$55.98M -$76.62M -$21.85M
Depreciation & Amortization $514K $509K $502K $502K $504K $503K $500K $494K
Stock-Based Compensation $16.06M $11.47M $10.00M $9.70M $14.68M $29.75M $56.60M $7.16M
Change in Receivables -$18.93M -$2.70M -$882K -$24.62M $0 -- -- --
Change in Inventory -$1.83M -$8.02M -$3.92M -$2.10M $0 -- -- --
Change in Payables -$2.97M $4.29M $1.93M $733K -$3.34M $2.58M $2.53M -$4.30M
Operating Cash Flow $25.98M $48.70M $43.45M -$12.61M -$32.75M -$23.99M -$14.93M -$17.65M
Capital Expenditure -$40K -$58K -$1.0K -$9.0K -$5.0K -$8.0K -$191K -$8.0K
Free Cash Flow $25.94M $48.65M $43.45M -$12.62M -$32.76M -$24.00M -$15.12M -$17.66M
Purchases of Investments -$101.3M -$187.8M -$163.2M -$59.41M -$45.36M -$47.55M -$47.77M -$145.9M
Investing Cash Flow $37.98M -$125.4M -$91.44M -$7.92M $22.94M $6.44M $4.04M -$120.9M
Share Repurchases -$4.0K -- -- -- $0 -- -- --
Financing Cash Flow -$1.04M -$99.90M $218.2M $15.69M $3.22M $57.06M $2.27M $152.7M
Net Change in Cash $62.92M -$176.6M $170.2M -$4.83M -$6.60M $39.52M -$8.61M $14.18M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 98.6% -- -- -- -- -- -- -- -- -4.0%
Operating Margin 4.9% -- -- -- -- -- -- -- -- -573.8%
Net Profit Margin 11.0% -- -- -- -- -- -- -- -- -831.6%
Return on Equity (ROE) 4.6% -71.7% -24.8% -232.6% -173.7% -54.1% -205.9% -43.8% -57.4% -351.2%
Return on Assets (ROA) 3.7% -53.1% -21.6% -90.8% -86.9% -37.9% -80.6% -30.9% -39.4% -216.8%
Current Ratio 5.80x 15.68x 14.89x 2.14x 2.80x 5.83x 4.26x 13.14x 10.38x 2.23x
Quick Ratio 5.55x 15.55x 14.75x 2.00x 2.66x 5.71x 4.18x 13.14x 9.87x 2.23x
Debt to Equity 0.12x 0.22x 0.00x 0.01x 0.03x 0.00x 0.03x -- -- --
Revenue Growth (YoY) -- -- -- -- -- -- -- -- -- +138.8%
Gross Profit Growth (YoY) -- -- -- -- -- -- -- -- -- -123.0%
10Y Revenue / Share Growth -97.8% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Return on Equity (ROE) 19.4% 4.6% -15.9% -75.4% -85.3% -71.7% -49.6% -23.3%
Return on Assets (ROA) 15.8% 3.7% -13.1% -54.5% -62.3% -53.1% -44.2% -21.5%
Current Ratio 5.62x 5.80x 16.08x 15.13x 19.64x 15.68x 17.26x 29.24x
Quick Ratio 5.32x 5.55x 15.88x 15.01x 18.43x 15.55x 17.16x 29.08x
Debt to Equity 0.11x 0.12x 0.11x 0.22x 0.23x 0.22x 0.01x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001484565) · from September 30, 2013 Data through March 31, 2026 · synced Nov 20, 2026, 05:21 UTC · Open in terminal